More Cabio Biotech (wuhan) Co. Ltd. Class A news
Cabio Biotech (wuhan) Co. Ltd. Class ASSE: 688089

Special Report on Deposit and Actual Use of Raised Funds in 2025

Apr 23, 2026 · Issued by Cabio Biotech (wuhan) Co. Ltd. Class A via Shanghai Stock Exchange
Special Report on Deposit and Actual Use of Raised Funds in 2025

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment